Compare Amnis Corporation vs WaferGen Bio-systems
Customers evaluate the quality of Amnis Corporation's products using the following success metrics.
Overview
Amnis Corporation is 26 yrs old and is based in United States.
Amnis Corporation offers high speed cell imaging for research and diagnostics
WaferGen Bio-systems is 22 yrs old and is based in United States.
WaferGen markets SmartChip TE (Target Enrichment for Next-Generation Sequencing (NGS)) and SmartChip MyDesign (high-throughput quantitative PCR) products. SmartChip TE addresses CLIA-certified and clinical research laboratories' significant unmet needs in sequencing-based testing by providing uniform coverage of targeted genes, yielding better test specificity and sensitivity. The superior performance of this new product is based on WaferGen's proprietary technology that relies on massively parallel singleplex PCR reactions, where amplification is cleaner and better controlled, thereby providing more accurate diagnostic test results in the downstream sequencing step. On the qPCR side, the SmartChip MyDesign System has a powerful value proposition of content design flexibility, cost-effectiveness, and no need for pre-amplification.
Demo Video
Leadership
Allan H Stephan (Founder)
Amjad Huda (Chief Financial Officer)
Investors
Luminex, Merck KGaA
Takara Bio, Yorkville Advisors
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Amnis Corporation has not claimed their profile.
Work for Amnis Corporation? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Amnis Corporation?
Claim your profile now.
Information not available because WaferGen Bio-systems has not claimed their profile.
Work for WaferGen Bio-systems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for WaferGen Bio-systems?
Claim your profile now.